Abdominal aortic aneurysm

From Vero - Wikipedia
Jump to navigation Jump to search

Template:Short description Template:Cs1 config Template:Distinguish Template:Infobox medical condition (new)

Abdominal aortic aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than normal.<ref name=Kent2014>Template:Cite journal</ref> An AAA usually causes no symptoms, except during rupture.<ref name=Kent2014/> Occasionally, abdominal, back, or leg pain may occur.<ref name=AFP2006>Template:Cite journal</ref> Large aneurysms can sometimes be felt by pushing on the abdomen.<ref name=AFP2006/> Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death.<ref name=Kent2014/><ref name=Spa2014>Template:Cite journal</ref>

AAAs occur most commonly in men, those over 50, and those with a family history of the disease.<ref name=Kent2014/> Additional risk factors include smoking, high blood pressure, and other heart or blood vessel diseases.<ref name=Wit2011>Template:Cite journal</ref> Genetic conditions with an increased risk include Marfan syndrome and Ehlers–Danlos syndrome.<ref name=CDC2014/> AAAs are the most common form of aortic aneurysm.<ref name=CDC2014/> About 85% occur below the kidneys, with the rest either at the level of or above the kidneys.<ref name=Kent2014/> In the United States, screening with abdominal ultrasound is recommended for males between 65 and 75 years of age with a history of smoking.<ref name=USP2014>Template:Cite journal</ref> In the United Kingdom and Sweden, screening all men over 65 is recommended.<ref name=Kent2014/><ref name=Sv2014>Template:Cite journal</ref> Once an aneurysm is found, further ultrasounds are typically done regularly until an aneurysm meets a threshold for repair.<ref name=AFP2006/>

Abstinence from cigarette smoking is the single best way to prevent the disease.<ref name=Kent2014/> Other methods of prevention include treating high blood pressure, treating high blood cholesterol, and avoiding being overweight.<ref name=Kent2014/> Surgery is usually recommended when the diameter of an AAA grows to >5.5 cm in males and >5.0 cm in females.<ref name=Kent2014/> Other reasons for repair include symptoms and a rapid increase in size, defined as more than one centimeter per year.<ref name=AFP2006/> Repair may be either by open surgery or endovascular aneurysm repair (EVAR).<ref name=Kent2014/> As compared to open surgery, EVAR has a lower risk of death in the short term and a shorter hospital stay, but may not always be an option.<ref name=Kent2014/><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> There does not appear to be a difference in longer-term outcomes between the two.<ref>Template:Cite journal</ref> Repeat procedures are more common with EVAR.<ref>Template:Cite journal</ref>

AAAs affect 2-8% of males over the age of 65.<ref name=Kent2014/> They are five times more common in men.<ref name=Kumar2020>Template:Cite book</ref> In those with an aneurysm less than 5.5 cm, the risk of rupture in the next year is below 1%.<ref name=Kent2014/> Among those with an aneurysm between 5.5 and 7 cm, the risk is about 10%, while for those with an aneurysm greater than 7 cm the risk is about 33%.<ref name=Kent2014/> Mortality if ruptured is 85% to 90%.<ref name=Kent2014/> Globally, aortic aneurysms resulted in 168,200 deaths in 2013, up from 100,000 in 1990.<ref name=GBD2015De>Template:Cite journal</ref><ref>Template:Cite journal</ref> In the United States AAAs resulted in between 10,000 and 18,000 deaths in 2009.<ref name=CDC2014>Template:Cite web</ref> Template:TOC limit

Signs and symptoms

File:Abdominal Aortic Aneurysm Location.png
Abdominal aortic aneurysm location

The vast majority of aneurysms are asymptomatic. However, as the abdominal aorta expands and/or ruptures, the aneurysm may become painful and lead to pulsating sensations in the abdomen or pain in the chest, lower back, legs, or scrotum.<ref name="harrisons">Template:Cite book</ref>

Complications

The complications include rupture, peripheral embolization, acute aortic occlusion, and aortocaval (between the aorta and inferior vena cava) or aortoduodenal (between the aorta and the duodenum) fistulae. On physical examination, a palpable and pulsatile abdominal mass can be noted. Bruits can be present in case of renal or visceral arterial stenosis.<ref name=emedicine/>

The signs and symptoms of a ruptured AAA may include severe pain in the lower back, flank, abdomen, or groin. A mass that pulses with the heartbeat may also be felt.<ref name=Spa2014/> The bleeding can lead to a hypovolemic shock with low blood pressure and a fast heart rate, which may cause fainting.<ref name=Spa2014/> The mortality of AAA rupture is as high as 90 percent. 65 to 75 percent of patients die before they arrive at the hospital and up to 90 percent die before they reach the operating room.<ref name=SmallAneurysmTrial>Template:Cite journal</ref> The bleeding can be retroperitoneal or into the abdominal cavity. Rupture can also create a connection between the aorta and intestine or inferior vena cava.<ref name=Treska>Treska V. et al.:Aneuryzma břišní aorty, Prague, 1999, Template:ISBN</ref> Flank ecchymosis (appearance of a bruise) is a sign of retroperitoneal bleeding and is also called Grey Turner's sign.<ref name=emedicine/><ref name=Cecil>Template:Cite book</ref>

Causes

The exact causes of the degenerative process remain unclear. There are, however, some hypotheses and well-defined risk factors.<ref name="pmid25884861">Template:Cite journal</ref>

  • Tobacco smoking: More than 90% of people who develop an AAA have smoked at some point in their lives.<ref name="Greenhalgh RM, Powell JT 2008 494–501">Template:Cite journal</ref>
  • Alcohol and hypertension: The inflammation caused by prolonged use of alcohol and hypertensive effects from abdominal edema which leads to hemorrhoids, esophageal varices, and other conditions, is also considered a long-term cause of AAA.Template:Citation needed
  • Genetic influences: The influence of genetic factors is high. AAA is four to six times more common in male siblings of known patients, with a risk of 20–30%.<ref name=siblings>Template:Cite journal</ref> The high familial prevalence rate is most notable in male individuals.<ref>Template:Cite journal</ref> There are many hypotheses about the exact genetic disorder that could cause a higher incidence of AAA among male members of the affected families. Some have presumed that the influence of alpha 1-antitrypsin deficiency could be crucial, while other experimental works favor the hypothesis of X-linked mutation, which would explain the lower incidence in heterozygous females. Other hypotheses of genetic causes have also been formulated.<ref name=emedicine/> Connective tissue disorders, such as Marfan syndrome and Ehlers-Danlos syndrome, have also been strongly associated with AAA.<ref name=Treska/> Both relapsing polychondritis and pseudoxanthoma elasticum may cause abdominal aortic aneurysm.<ref name="Bolognia">Template:Cite book</ref>
  • Atherosclerosis: The AAA was long considered to be caused by atherosclerosis because the walls of the AAA frequently carry an atherosclerotic burden. However, this hypothesis cannot explain the initial defect and the development of occlusion, which is observed in the process.<ref name=emedicine/> Another hypothesis is that plaque buildup can cause a feed-forward dysfunction in the signaling among neurons that regulate pressure in the aorta. This feed-forward process leads to an over-pressuring condition that ruptures the aorta.<ref>Template:Cite journal</ref>
  • Other causes of the development of AAA include: infection, trauma, arteritis, and cystic medial necrosis.<ref name=Treska/>

Pathophysiology

File:Aortadiagramgray.png
A plate from Gray's Anatomy with yellow lines depicting the most common infrarenal location of the AAA
File:Aortic Aneurism 76F 3D SR Nevit Dilmen.stl
3D file showing an aortic aneurysm

The most striking histopathological changes of the aneurysmatic aorta are seen in the tunica media and intima layers. These changes include the accumulation of lipids in foam cells, extracellular free cholesterol crystals, calcifications, thrombosis, and ulcerations and ruptures of the layers. Adventitial inflammatory infiltrate is present.<ref name=Treska/> However, the degradation of the tunica media by means of a proteolytic process seems to be the basic pathophysiologic mechanism of AAA development. Some researchers report increased expression and activity of matrix metalloproteinases in individuals with AAA. This leads to the elimination of elastin from the media, rendering the aortic wall more susceptible to the influence of blood pressure.<ref name=emedicine/> Other reports have suggested the serine protease granzyme B may contribute to aortic aneurysm rupture through the cleavage of decorin, leading to disrupted collagen organization and reduced tensile strength of the adventitia.<ref name="pmid20035050">Template:Cite journal</ref><ref name="pmid21900960">Template:Cite journal</ref> There is also a reduced amount of vasa vasorum in the abdominal aorta (compared to the thoracic aorta); consequently, the tunica media must rely mostly on diffusion for nutrition, which makes it more susceptible to damage.<ref name="MacSweeney">Template:Cite journal</ref>

Hemodynamics affect the development of AAA, which has a predilection for the infrarenal aorta. The histological structure and mechanical characteristics of the infrarenal aorta differ from those of the thoracic aorta. The diameter decreases from the root to the aortic bifurcation, and the wall of the infrarenal aorta also contains a lesser proportion of elastin. The mechanical tension in the abdominal aortic wall is therefore higher than in the thoracic aortic wall. The elasticity and distensibility also decline with age, which can result in gradual dilatation of the segment. Higher intraluminal pressure in patients with arterial hypertension markedly contributes to the progression of the pathological process.<ref name=Treska/> Suitable hemodynamic conditions may be linked to specific intraluminal thrombus (ILT) patterns along the aortic lumen, which in turn may affect AAA's development.<ref name="Biasetti">Template:Cite journal</ref>

Diagnosis

An abdominal aortic aneurysm is usually diagnosed by physical exam, abdominal ultrasound, or CT scan. Plain abdominal radiographs may show the outline of an aneurysm when its walls are calcified. However, the outline will be visible by X-ray in less than half of all aneurysms. Ultrasonography is used to screen for aneurysms and to determine their size if present. Additionally, free peritoneal fluid can be detected. It is non-invasive and sensitive, but the presence of bowel gas or obesity may limit its usefulness.<ref name="pmid39055063">Template:Cite journal</ref> CT scan has nearly 100% sensitivity for an aneurysm and is also useful in preoperative planning, detailing the anatomy and possibility for endovascular repair. In the case of suspected rupture, it can also reliably detect retroperitoneal fluid. Alternative less often used methods for visualization of an aneurysm include MRI and angiography.<ref name="pmid29979239">Template:Cite journal</ref>

An aneurysm ruptures if the mechanical stress (tension per area) exceeds the local wall strength; consequently, peak wall stress (PWS),<ref name="Fillinger_2003">Template:Cite journal</ref> mean wall stress (MWS),<ref>Template:Cite journal</ref> and peak wall rupture risk (PWRR)<ref>Template:Cite journal</ref> are more reliable parameters than diameter to assess AAA rupture risk. Medical software allows computing these rupture risk indices from standard clinical CT data and provides a patient-specific AAA rupture risk diagnosis.<ref>Template:Cite web</ref><ref name=":1">Template:Cite journal</ref><ref name=":2">Template:Cite journal</ref> This type of biomechanical approach has been shown to accurately predict the location of AAA rupture.<ref name=":1" /><ref name=":2" /><ref>Template:Cite journal</ref>

Classification

Size classification
Ectatic or
mild dilatation
>2.0 cm and <3.0 cm<ref name=lumb2014>Template:Cite book Page 56 in: Template:Cite book</ref>
Moderate 3.0 - 5.0 cm<ref name=lumb2014/>
Large or severe >5.0<ref name=lumb2014/> or 5.5<ref name=screening/> cm

Abdominal aortic aneurysms are commonly divided according to their size and symptomatology. An aneurysm is usually defined as an outer aortic diameter over 3 cm (normal diameter of the aorta is around 2 cm),<ref name=ACCAHA2022/> or more than 50% of normal diameter.<ref name="SolomonKent2014">Template:Cite journal</ref> If the outer diameter exceeds 5.5 cm, the aneurysm is considered to be large.<ref name=screening/> Ruptured AAA should be suspected in any person older than 60 who experiences collapse, unexplained low blood pressure, or sudden-onset back or abdominal pain. Abdominal pain, shock, and a pulsatile mass are only present in a minority of cases.Template:Citation needed Although an unstable person with a known aneurysm may undergo surgery without further imaging, the diagnosis will usually be confirmed using CT or ultrasound scanning.Template:Citation needed

The suprarenal aorta normally measures about 0.5 cm larger than the infrarenal aorta.<ref>Template:Cite web</ref>

Differential diagnosis

Aortic aneurysm rupture may be mistaken for the pain of kidney stones, or muscle related back pain.<ref name=Spa2014/>

Prevention

In terms of prevention, the following are effective measures to reduce the risk of developing a AAA:<ref name="ACCAHA2022">Template:Cite journal</ref>

Screening

Repeat ultrasound frequency after diagnosis
AAA size
in cm
SVS<ref name="SVSguidelines2018"/>
(2018)
ESVS (2024)<ref name="ESVSguidelines2024"/> RESCAN<ref name=Brown2013/>
(2013)
Men Women
2.5–2.9 10 years 5 years Template:N/a
3.0–3.9 3 years 3 years 2 to 3 years
4.0–4.4 1 year 1 year 1 to 2 years
4.5–4.9 1 year 6 months 1 year
5.0–5.4 6 months Surgery 6 months

The U.S. Preventive Services Task Force (USPSTF) recommends a single screening abdominal ultrasound for abdominal aortic aneurysm in males aged 65 to 75 years who have a history of smoking.<ref name=USPSTF2019>Template:Cite journal</ref> Among this group who does not smoke, screening may be selective.<ref name=USPSTF2019/> It is unclear if screening is useful in women who have smoked and the USPSTF recommends against screening in women who have never smoked.<ref name=USP2014/><ref name=Ali2016>Template:Cite journal</ref>

In the United Kingdom, the NHS AAA Screening Programme invites men in England for screening during the year they turn 65. Men over 65 can contact the programme to arrange to be screened.<ref>Template:Cite web</ref>

In Sweden one time screening is recommended in all males over 65 years of age.<ref name="Kent2014" /><ref name="Sv2014" /> This has been found to decrease the risk of death from AAA by 42% with a number needed to screen just over 200.<ref name="Ali2016" /> In those with a close relative diagnosed with an aortic aneurysm, Swedish guidelines recommend an ultrasound at around 60 years of age.<ref>Template:Cite web</ref>

Australia has no guideline on screening.<ref>Template:Cite journal</ref>

Repeat ultrasounds should be carried out in those who have an aortic size greater than 3.0 cm.<ref name=Brown2013/> Although recommendations vary between guidelines, in those whose aorta is between 3.0 and 3.9 cm this may be every three years, if between 4.0 and 4.4 cm every two years, and if between 4.5 and 5.4 cm every year.<ref name=Brown2013>Template:Cite journal</ref>

Management

The treatment options for asymptomatic AAA are conservative management, surveillance with a view to eventual repair, and immediate repair. Two modes of repair are available for an AAA: open aneurysm repair, and endovascular aneurysm repair (EVAR). An intervention is often recommended if the aneurysm grows more than 1 cm per year or it is bigger than 5.5 cm.<ref name=":0">Template:Cite journal</ref> Repair is also indicated for symptomatic aneurysms. Ten years after open AAA repair, the overall survival rate was 59%.<ref>Template:Cite journal</ref> Mycotic abdominal aorta aneurysm (MAAA) is a rare and life-threatening condition. Because of its rarity, there is a lack of adequately powered studies and consensus on its treatment and follow-up. A management protocol on the management of mycotic abdominal aortic aneurysm was recently published in the Annals of Vascular Surgery by Premnath et al.<ref>Template:Cite journal</ref>

Conservative

Conservative management is indicated in people where repair carries a high mortality risk and in patients where repair is unlikely to improve life expectancy. The mainstay of the conservative treatment is smoking cessation.Template:Citation needed

Surveillance is indicated in small asymptomatic aneurysms (less than 5.5 cm) where the risk of repair exceeds the risk of rupture.<ref name=":0" /> As an AAA grows in diameter, the risk of rupture increases. Surveillance until an aneurysm has reached a diameter of 5.5 cm has not been shown to have a higher risk as compared to early intervention.<ref name=SmallAneurysm>Template:Cite journal</ref><ref name=ADAM>Template:Cite journal</ref>

Medication

No medical therapy has been proven to be effective at decreasing the growth rate or rupture rate of asymptomatic AAAs.<ref name=Kent2014/> Blood pressure and lipids should, however, be treated per usual. The use of statins in moderate or high intensity in patients with atherosclerotic AAAs reduces the risk of adverse events such as myocardial infarction and stroke.<ref name="ACCAHA2022"/>

Surgery

The threshold for repair varies slightly from individual to individual, depending on the balance of risks and benefits when considering repair versus ongoing surveillance. The size of an individual's native aorta may influence this, along with the presence of comorbidities that increase operative risk or decrease life expectancy.<ref name=":0" />

Evidence, however, favors elective repair if the AAA size is greater than 5.5 cm in men and 5.0 cm in women.<ref name="SVSguidelines2018">Template:Cite journal</ref><ref name="ESVSguidelines2024">Template:Cite journal</ref> Surgery is usually recommended for symptomatic patients. Limited evidence suggests intervention in case of saccular aneurysms, as their shape may result in earlier rupture, as well as rapidly-growing AAAs (≥0.5 cm in 6 months or ≥1 cm in one year).<ref name="ACCAHA2022"/>

Open repair

Template:Main Open repair is indicated in young patients as an elective procedure, or in growing or large, symptomatic or ruptured aneurysms. The aorta must be clamped during the repair, denying blood to the abdominal organs and sections of the spinal cord; this can cause a range of complications. As it is essential to perform the critical part of the operation quickly, the incision is typically made large enough to facilitate the fastest repair. Recovery after open AAA surgery takes significant time. The minimums are a few days in intensive care, a week total in the hospital, and a few months before full recovery.Template:Citation needed

Endovascular repair

File:Endovasc.jpg
Abdominal aortic endoprosthesis, CT scan, original aneurysm marked in blue

Template:Main Endovascular repair first became practical in the 1990s and although it is now an established alternative to open repair, its role is yet to be clearly defined. It is generally indicated in older, high-risk patients or patients unfit for open repair. However, endovascular repair is feasible for only a portion of AAAs, depending on the morphology of the aneurysm. The main advantages over open repair are that there is less peri-operative mortality, less time in intensive care, less time in hospital overall, and an earlier return to normal activity. Disadvantages of endovascular repair include a requirement for more frequent ongoing hospital reviews and a higher chance of further required procedures. According to the latest studies, the EVAR procedure does not offer any benefit for overall survival or health-related quality of life compared to open surgery, although aneurysm-related mortality is lower.<ref name=pmid16782510>Template:Cite journal</ref><ref name=pmid17502634>Template:Cite journal</ref><ref name=EVAR1>Template:Cite journal</ref><ref name=DREAM>Template:Cite journal</ref> In patients unfit for open repair, EVAR plus conservative management was associated with no benefit, more complications, subsequent procedures and higher costs compared to conservative management alone.<ref name=EVAR2>Template:Cite journal</ref> Endovascular treatment for paraanastomotic aneurysms after aortobiiliac reconstruction is also a possibility.<ref>Template:Cite journal</ref> A 2017 Cochrane review found tentative evidence of no difference in outcomes between endovascular and open repair of ruptured AAA in the first month.<ref>Template:Cite journal</ref>

Rupture

In those with aortic rupture of the AAA, treatment is immediate surgical repair. There appear to be benefits to allowing permissive hypotension and limiting the use of intravenous fluids during transport to the operating room.<ref>Template:Cite journal</ref>

Prognosis

AAA Size (cm) Growth rate (cm/yr)<ref>Template:Cite journal</ref> Annual rupture risk (%)<ref>Template:Cite journal</ref>
3.0–3.9 0.39 0
4.0–4.9 0.36 0.5–5
5.0–5.9 0.43 3–15
6.0–6.9 0.64 10–20
>=7.0 - 20–50

Although the current standard of determining rupture risk is based on maximum diameter, it is known that smaller AAAs that fall below this threshold (diameter<5.5 cm) may also rupture, and larger AAAs (diameter>5.5 cm) may remain stable.<ref>Template:Cite journal</ref><ref name=pmid9808857>Template:Cite journal</ref> In one report, it was shown that 10–24% of ruptured AAAs were less than 5 cm in diameter.<ref name=pmid9808857/> It has also been reported that of 473 non-repaired AAAs examined from autopsy reports, there were 118 cases of rupture, 13% of which were less than 5 cm in diameter. This study also showed that 60% of the AAAs greater than 5 cm (including 54% of those AAAs between 7.1 and 10 cm) never experienced rupture.<ref name="Vorp DA 2007 1887–902">Template:Cite journal</ref> Vorp et al. later deduced from the findings of Darling et al. that if the maximum diameter criterion were followed for the 473 subjects, only 7% (34/473) of cases would have died from rupture before surgical intervention as the diameter was less than 5 cm, with 25% (116/473) of cases possibly undergoing unnecessary surgery since these AAAs may never have ruptured.<ref name="Vorp DA 2007 1887–902"/>

Alternative methods of rupture assessment have been recently reported. The majority of these approaches involve the numerical analysis of AAAs using the common engineering technique of the finite element method (FEM) to determine the wall stress distributions. Recent reports have shown that these stress distributions have been shown to correlate to the overall geometry of the AAA rather than solely to the maximum diameter.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref name="Doyle BJ, Callanan A, Burke PE, et al. 2009 443–54">Template:Cite journal</ref> It is also known that wall stress alone does not completely govern failure as an AAA will usually rupture when the wall stress exceeds the wall strength. In light of this, rupture assessment may be more accurate if the patient-specific wall stress is coupled together with patient-specific wall strength. A noninvasive method of determining patient-dependent wall strength was recently reported,<ref>Template:Cite journal</ref> with more traditional approaches to strength determination via tensile testing performed by other researchers in the field.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> Some of the more recently proposed AAA rupture-risk assessment methods include: AAA wall stress;<ref name = "Fillinger_2003"/><ref name = "Fillinger_2002">Template:Cite journal</ref><ref>Template:Cite journal</ref> AAA expansion rate;<ref>Template:Cite journal</ref> degree of asymmetry;<ref name="Doyle BJ, Callanan A, Burke PE, et al. 2009 443–54"/> presence of intraluminal thrombus (ILT);<ref>Template:Cite journal</ref> a rupture potential index (RPI);<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> a finite element analysis rupture index (FEARI);<ref>Template:Cite journal</ref> biomechanical factors coupled with computer analysis;<ref>Template:Cite journal</ref> growth of ILT;<ref>Template:Cite journal</ref> geometrical parameters of the AAA;<ref>Template:Cite journal</ref> and also a method of determining AAA growth and rupture based on mathematical models.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref>

The postoperative mortality for an already ruptured AAA has slowly decreased over several decades but remains higher than 40%.<ref name=repair>Template:Cite journal</ref> However, if the AAA is surgically repaired before rupture, the postoperative mortality rate is substantially lower, approximately 1-6%.<ref>Template:Cite journal</ref>

Epidemiology

The occurrence of AAA varies by ethnicity. In the United Kingdom, the rate of AAA in Caucasian men older than 65 years is about 4.7%, while in Asian men it is 0.45%.<ref>Template:Cite journal</ref> It is also less common in individuals of African, and Hispanic heritage.<ref name=Kent2014/> They occur four times more often in men than in women.<ref name=Kent2014/>

There are at least 13,000 deaths yearly in the U.S. secondary to AAA rupture.<ref name=Kent2014/> The peak number of new cases per year among males is around 70 years of age, and the percentage of males affected over 60 years is 2–6%. The frequency is much higher in smokers than in non-smokers (8:1), and the risk decreases slowly after smoking cessation.<ref name=smoking>Template:Cite journal</ref> In the U.S., the incidence of AAA is 2–4% in the adult population.<ref name=emedicine>Template:EMedicine</ref>

Rupture of the AAA occurs in 1–3% of men aged 65 or more, for whom the mortality rate is 70–95%.<ref name=screening>Template:Cite journal</ref>

History

The first historical records about AAA are from Ancient Rome in the 2nd century AD, when Greek surgeon Antyllus tried to treat the AAA with proximal and distal ligature, central incision and removal of thrombotic material from the aneurysm. However, attempts to treat the AAA surgically were unsuccessful until 1923. In that year, Rudolph Matas (who also proposed the concept of endoaneurysmorrhaphy), performed the first successful aortic ligation on a human.<ref name=livesay>Template:Cite journal</ref> Other methods that were successful in treating the AAA included wrapping the aorta with polyethene cellophane, which induced fibrosis and restricted the growth of the aneurysm. Endovascular aneurysm repair was first performed in the late 1980s and has been widely adopted in the subsequent decades. Endovascular repair was first used for treating a ruptured aneurysm in Nottingham in 1994.<ref>Template:Cite journal</ref>

Society and culture

Theoretical physicist Albert Einstein underwent an operation for an abdominal aortic aneurysm in 1949 that was performed by Rudolph Nissen, who wrapped the aorta with polyethylene cellophane. Einstein's aneurysm ruptured on April 13, 1955. He declined surgery, saying, "I want to go when I want. It is tasteless to prolong life artificially. I have done my share, it is time to go. I will do it elegantly." He died five days later at age 76.<ref>Template:Cite news</ref>

Actor John Banner, January 28, 1910 – January 28, 1973, famous for portraying Sgt. Shultz on Hogan's Heroes, died from an abdominal aortic aneurysm on his 63rd birthday while visiting friends in Vienna.

Actress Lucille Ball died on April 26, 1989, from an abdominal aortic aneurysm. At the time of her death, she was in Cedars-Sinai Medical Center recovering from emergency surgery performed just six days earlier because of a dissecting aortic aneurysm near her heart. Ball was at increased risk as she had been a heavy smoker for decades.<ref name="Ball Dies of Aorta Failure">Template:Cite news</ref>

Musician Conway Twitty died in June 1993 from an abdominal aortic aneurysm at the age of 59, two months before the release of what would be his final studio album, Final Touches.Template:Citation needed

Actor George C. Scott died in 1999, aged 71, from a ruptured abdominal aortic aneurysm.Template:Citation needed

In 2001, former presidential candidate Bob Dole underwent surgery for an abdominal aortic aneurysm in which a team led by vascular surgeon Kenneth Ouriel inserted a stent graft.<ref name=twsSEPgh45>Template:Cite news</ref>

Actor Robert Jacks, who played Leatherface in Texas Chainsaw Massacre: The Next Generation, died from an abdominal aneurysm on August 8, 2001, one day shy of his 42nd birthday. When Jacks was a child, his father died from the same cause.

Actor Tommy Ford died of abdominal aneurysm in October 2016 at 52 years old.<ref>Template:Cite news</ref>

Gary Gygax, co-creator of Dungeons & Dragons, died from an abdominal aortic aneurysm in 2008, at the age of 69.

Harvey Korman died on May 29, 2008, aged 81, as the result of complications from a ruptured abdominal aortic aneurysm he had suffered four months earlier.

Research

Risk assessment

There have been many calls for alternative approaches to rupture risk assessment over the past number of years, with many believing that a biomechanics-based approach may be more suitable than the current diameter approach. Numerical modeling is a valuable tool to researchers allowing approximate wall stresses to be calculated, thus revealing the rupture potential of a particular aneurysm. Experimental models are required to validate these numerical results and provide further insight into the biomechanical behavior of the AAA. In vivo, AAAs exhibit a varying range of material strengths<ref>Template:Cite journal</ref> from localised weak hypoxic regions<ref>Template:Cite journal</ref> to much stronger regions and areas of calcifications.<ref>Template:Cite journal</ref>

Finding ways to predict future AAA growth is seen as a research priority.<ref>Template:Cite journal</ref>

Another related line of research is utilizing mathematical decision modeling (e.g., Markov decision processes) to determine improved treatment policies. Initial results suggest that a more dynamic policy could provide benefits, although such claims have not been clinically verified.<ref>Template:Cite book</ref><ref>Template:Cite journal</ref> A study recently showed that aneurysms can be accurately predicted as to whether they are stable (lacking repair or intervention), requiring repair, or at risk of rupture from scans years prior to any event based on a machine-learning based classification tool.<ref>Template:Cite journal</ref>

Experimental models

Experimental models can now be manufactured using a novel technique involving the injection-moulding lost-wax manufacturing process to create patient-specific anatomically correct AAA replicas.<ref>Template:Cite journal</ref> Work has also focused on developing more realistic material analogues to those in vivo, and recently a novel range of silicone-rubbers was created allowing the varying material properties of the AAA to be more accurately represented.<ref>Template:Cite journal</ref> These rubber models can also be used in a variety of experimental situations, from stress analysis using the photoelastic method<ref>Template:Cite journal</ref> New endovascular devices are being developed that are able to treat more complex and tortuous anatomies.<ref>Template:Cite journal</ref>

Prevention and treatment

An animal study showed that removing a single protein prevents early damage in blood vessels from triggering a later-stage, frequently lethal complication. By eliminating the gene for a signaling protein called cyclophilin A (CypA) from a strain of mice, researchers were able to provide complete protection against abdominal aortic aneurysm.<ref>Template:Cite magazine</ref>

Other recent research identified Granzyme B (GZMB) (a protein-degrading enzyme) to be a potential target in the treatment of abdominal aortic aneurysms. Elimination of this enzyme in mice models both slowed the progression of aneurysms and improved survival.<ref>Template:Cite journal</ref><ref>Template:Cite web</ref>

Preclinical research

The mechanisms that lead to AAA development are still not completely understood at a cellular and molecular level. To better understand the pathophysiology of AAA, it is often necessary to use experimental animal models. It is often questioned how well these models translate to human disease. Even though no animal model exactly represents the human condition, all the existing ones focus on one different pathophysiological aspect of the disease. Combining the results from different animal models with clinical research can provide a better overview of the AAA pathophysiology. The most common animal models are rodents (mice and rats), although, for certain studies, such as testing preclinical devices or surgical procedures, large animal models (pig, sheep) are more frequently used. The rodent models of AAA can be classified according to different aspects. There are dissecting models vs non-dissecting models and genetically determined models vs chemically induced models. The most commonly used models are the angiotensin-II infusion into ApoE knockout mice (dissecting model, chemically induced), the calcium chloride model (non-dissecting, chemically induced), and the elastase model (non-dissecting, chemically induced model).<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> A recent study has shown that β-Aminopropionitrile plus elastase application to abdominal aorta causes more severe aneurysm in mice as compared to elastase alone.<ref>Template:Cite journal</ref>

References

Template:Reflist

Template:Medical resources Template:Commons category

Template:Vascular diseases

de:Aortenaneurysma#Bauchaortenaneurysma